GCP ClinPlus
Date | Investors | Amount | Round |
---|---|---|---|
* | CNY100m | Early VC | |
Total Funding | AUD21.3m |
Related Content
Recent News about GCP ClinPlus
EditGCP ClinPlus specializes in providing precise clinical study services that adhere to international standards. Over the past 20 years, the company has grown significantly, becoming one of the leading clinical study service providers in China. GCP ClinPlus serves a diverse range of clients, including pharmaceutical companies, biotech firms, and medical device manufacturers, both locally and globally. The company operates in the clinical research market, focusing on the design, management, and execution of clinical trials. Its business model revolves around offering end-to-end clinical study solutions, from planning and regulatory compliance to data management and analysis. Revenue is generated through service contracts with clients who require comprehensive clinical trial support.
Keywords: clinical trials, pharmaceutical, biotech, medical devices, regulatory compliance, data management, global services, China, clinical research, end-to-end solutions.